A Study to Evaluate the Safety and Effectiveness of MSP01-T for Bowel Cleansing Before a Colonoscopy

Phase 3 Not yet recruiting 214 enrolled Mather's Pharm. Co., Ltd.

RandomizedParallel-groupDouble-blindDiagnostic

Summary

This study is being conducted to evaluate the safety and effectiveness of MSP01-T, a new bowel cleansing agent, in adults who are scheduled to undergo a colonoscopy. Participants will be randomly assigned to receive either MSP01-T or a comparator product. The study will assess how effectively MSP01-T cleans the bowel before the procedure and monitor any potential side effects. Adults aged 19 years and older who are planning to have a colonoscopy may be eligible to take part.

Timeline

Start: 2025-10
Primary completion: 2026-03
Completion: 2026-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	MSP01-R	Unknown	—	Oral
Subject	MSP01-T	Unknown	—	Oral

Indications

No indication recorded.